-
1
-
-
84901854786
-
Inhibition of α-glucosidase and glucose intestinal absorption by Thymelaea hirsuta fractions
-
S. Abid, A. Lekchiri, H. Mekhfi, A. Ziyyat, A. Legssyer, M. Aziz, and M. Bnouham Inhibition of α-glucosidase and glucose intestinal absorption by Thymelaea hirsuta fractions Journal of Diabetes 6 2014 351 359
-
(2014)
Journal of Diabetes 6
, pp. 351-359
-
-
Abid, S.1
Lekchiri, A.2
Mekhfi, H.3
Ziyyat, A.4
Legssyer, A.5
Aziz, M.6
Bnouham, M.7
-
2
-
-
84893468455
-
Fenofibrate-associated nephrotoxicity: A review of current evidence
-
R.L. Attridge, C.R. Frei, L. Ryan, J. Koeller, and W.D. Linn Fenofibrate-associated nephrotoxicity: a review of current evidence American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists 70 2013 1219 1225
-
(2013)
American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists
, vol.70
, pp. 1219-1225
-
-
Attridge, R.L.1
Frei, C.R.2
Ryan, L.3
Koeller, J.4
Linn, W.D.5
-
3
-
-
34548182594
-
PPAR dual agonists: Are they opening Pandora′s Box?
-
P. Balakumar, M. Rose, S.S. Ganti, P. Krishan, and M. Singh PPAR dual agonists: are they opening Pandora′s Box? Pharmacological Research: The Official Journal of the Italian Pharmacological Society 56 2007 91 98
-
(2007)
Pharmacological Research: The Official Journal of the Italian Pharmacological Society
, vol.56
, pp. 91-98
-
-
Balakumar, P.1
Rose, M.2
Ganti, S.S.3
Krishan, P.4
Singh, M.5
-
7
-
-
79960988152
-
Effects of the new dual PPAR alpha/delta agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism
-
B. Cariou, Y. Zair, B. Staels, and E. Bruckert Effects of the new dual PPAR alpha/delta agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism Diabetes Care 34 2011 2008 2014
-
(2011)
Diabetes Care
, vol.34
, pp. 2008-2014
-
-
Cariou, B.1
Zair, Y.2
Staels, B.3
Bruckert, E.4
-
8
-
-
77952997178
-
Control of macrophage activation and function by PPARs
-
A. Chawla Control of macrophage activation and function by PPARs Circulation Research 106 2010 1559 1569
-
(2010)
Circulation Research
, vol.106
, pp. 1559-1569
-
-
Chawla, A.1
-
10
-
-
84872292832
-
Design, development and evaluation of novel dual PPARdelta/PPARgamma agonists
-
S. Gathiaka, G. Nanayakkara, T. Boncher, O. Acevedo, J. Wyble, S. Patel, A. Patel, M.E. Shane, B. Bonkowski, J. Wieczorek, Y. Rong, K. Huggins, F. Smith, and R.H. Amin Design, development and evaluation of novel dual PPARdelta/PPARgamma agonists Bioorganic & Medicinal Chemistry Letters 23 2013 873 879
-
(2013)
Bioorganic & Medicinal Chemistry Letters
, vol.23
, pp. 873-879
-
-
Gathiaka, S.1
Nanayakkara, G.2
Boncher, T.3
Acevedo, O.4
Wyble, J.5
Patel, S.6
Patel, A.7
Shane, M.E.8
Bonkowski, B.9
Wieczorek, J.10
Rong, Y.11
Huggins, K.12
Smith, F.13
Amin, R.H.14
-
11
-
-
84942089920
-
α-Glucosidase inhibitory activity of the alabastrum of Edgeworthia gardneri (Wall.) Meisn
-
Y. Geng, H.M. Yang, H.Y. Xu, and J.S. Shi α-Glucosidase inhibitory activity of the alabastrum of Edgeworthia gardneri (Wall.) Meisn Journal of Food Science and Biotechnology 32 2013 967 971
-
(2013)
Journal of Food Science and Biotechnology
, vol.32
, pp. 967-971
-
-
Geng, Y.1
Yang, H.M.2
Xu, H.Y.3
Shi, J.S.4
-
12
-
-
33846641605
-
Design and synthesis of a novel class of dual PPARγ/δ agonists
-
I.C. Gonzalez, J. Lamar, F. Iradier, Y. Xu, L.L. Winneroski, J. York, N. Yumibe, R. Zink, C. Montrose-Rafizadeh, and G.J. Etgen Design and synthesis of a novel class of dual PPARγ/δ agonists Bioorganic & Medicinal Chemistry Letters 17 2007 1052 1055
-
(2007)
Bioorganic & Medicinal Chemistry Letters 17
, pp. 1052-1055
-
-
Gonzalez, I.C.1
Lamar, J.2
Iradier, F.3
Xu, Y.4
Winneroski, L.L.5
York, J.6
Yumibe, N.7
Zink, R.8
Montrose-Rafizadeh, C.9
Etgen, G.J.10
-
13
-
-
84893794489
-
Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications-A review
-
B. Grygiel-Gorniak Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications-a review Nutrition Journal 13 2014 17
-
(2014)
Nutrition Journal
, vol.13
, pp. 17
-
-
Grygiel-Gorniak, B.1
-
14
-
-
84862769372
-
In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy
-
T. He, L. Chen, Y. Chen, Y. Han, W.Q. Yang, and M.W. Jin In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy 26 2012 109 120
-
(2012)
Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy
, vol.26
, pp. 109-120
-
-
He, T.1
Chen, L.2
Chen, Y.3
Han, Y.4
Yang, W.Q.5
Jin, M.W.6
-
16
-
-
0025132245
-
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
-
I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
-
(1990)
Nature
, vol.347
, pp. 645-650
-
-
Issemann, I.1
Green, S.2
-
17
-
-
79952002653
-
Review: Effects of PPAR activation in the placenta and the fetus: Implications in maternal diabetes
-
A. Jawerbaum, and E. Capobianco Review: effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes Placenta 32 2011 S212 S217
-
(2011)
Placenta
, vol.32
, pp. S212-S217
-
-
Jawerbaum, A.1
Capobianco, E.2
-
19
-
-
0032699670
-
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting
-
S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting The Journal of Clinical Investigation 103 1999 1489 1498
-
(1999)
The Journal of Clinical Investigation
, vol.103
, pp. 1489-1498
-
-
Kersten, S.1
Seydoux, J.2
Peters, J.M.3
Gonzalez, F.J.4
Desvergne, B.5
Wahli, W.6
-
20
-
-
12944319825
-
Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes
-
H. Kim, M. Haluzik, O. Gavrilova, S. Yakar, J. Portas, H. Sun, U.B. Pajvani, P.E. Scherer, and D. LeRoith Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes Diabetologia 47 2004 2215 2225
-
(2004)
Diabetologia
, vol.47
, pp. 2215-2225
-
-
Kim, H.1
Haluzik, M.2
Gavrilova, O.3
Yakar, S.4
Portas, J.5
Sun, H.6
Pajvani, U.B.7
Scherer, P.E.8
LeRoith, D.9
-
21
-
-
84922200929
-
The peroxisome proliferator-activated receptor beta/delta agonist GW0742 has direct protective effects on right heart hypertrophy
-
B. Kojonazarov, H. Luitel, A. Sydykov, B.K. Dahal, M.J. Paul-Clark, S. Bonvini, A. Reed, R.T. Schermuly, and J.A. Mitchell The peroxisome proliferator-activated receptor beta/delta agonist GW0742 has direct protective effects on right heart hypertrophy Pulmonary Circulation 3 2013 926 935
-
(2013)
Pulmonary Circulation
, vol.3
, pp. 926-935
-
-
Kojonazarov, B.1
Luitel, H.2
Sydykov, A.3
Dahal, B.K.4
Paul-Clark, M.J.5
Bonvini, S.6
Reed, A.7
Schermuly, R.T.8
Mitchell, J.A.9
-
23
-
-
84860527078
-
Fibrates: Therapeutic potential for diabetic nephropathy?
-
I. Kouroumichakis, N. Papanas, P. Zarogoulidis, V. Liakopoulos, E. Maltezos, and D.P. Mikhailidis Fibrates: therapeutic potential for diabetic nephropathy? European Journal of Internal Medicine 23 2012 309 316
-
(2012)
European Journal of Internal Medicine
, vol.23
, pp. 309-316
-
-
Kouroumichakis, I.1
Papanas, N.2
Zarogoulidis, P.3
Liakopoulos, V.4
Maltezos, E.5
Mikhailidis, D.P.6
-
25
-
-
0037900979
-
Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors
-
C.H. Lee, P. Olson, and R.M. Evans Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors Endocrinology 144 2003 2201 2207
-
(2003)
Endocrinology
, vol.144
, pp. 2201-2207
-
-
Lee, C.H.1
Olson, P.2
Evans, R.M.3
-
26
-
-
20444424173
-
Roles of PPAR delta in lipid absorption and metabolism: A new target for the treatment of type 2 diabetes
-
S. Luquet, C. Gaudel, D. Holst, J. Lopez-Soriano, C. Jehl-Pietri, A. Fredenrich, and P.A. Grimaldi Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes Biochimica et Biophysica Acta 1740 2005 313 317
-
(2005)
Biochimica et Biophysica Acta
, vol.1740
, pp. 313-317
-
-
Luquet, S.1
Gaudel, C.2
Holst, D.3
Lopez-Soriano, J.4
Jehl-Pietri, C.5
Fredenrich, A.6
Grimaldi, P.A.7
-
27
-
-
84862004194
-
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach
-
Y. Ma, S.Q. Wang, W.R. Xu, R.L. Wang, and K.C. Chou Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach PLoS One 7 2012 e38546
-
(2012)
PLoS One
, vol.7
, pp. e38546
-
-
Ma, Y.1
Wang, S.Q.2
Xu, W.R.3
Wang, R.L.4
Chou, K.C.5
-
28
-
-
84889092515
-
Harnessing the benefits of PPARbeta/delta agonists
-
L.S. Mackenzie, and L. Lione Harnessing the benefits of PPARbeta/delta agonists Life Sciences 93 2013 963 967
-
(2013)
Life Sciences
, vol.93
, pp. 963-967
-
-
MacKenzie, L.S.1
Lione, L.2
-
29
-
-
84865507796
-
Lipid effects of peroxisome proliferator-activated receptor-delta agonist GW501516 in subjects with low high-density lipoprotein cholesterol: Characteristics of metabolic syndrome
-
E.J. Olson, G.L. Pearce, N.P. Jones, and D.L. Sprecher Lipid effects of peroxisome proliferator-activated receptor-delta agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome Arteriosclerosis, Thrombosis, and Vascular Biology 32 2012 2289 2294
-
(2012)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.32
, pp. 2289-2294
-
-
Olson, E.J.1
Pearce, G.L.2
Jones, N.P.3
Sprecher, D.L.4
-
30
-
-
80053521381
-
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity
-
E.M. Ooi, G.F. Watts, D.L. Sprecher, D.C. Chan, and P.H. Barrett Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity The Journal of Clinical Endocrinology and Metabolism 96 2011 E1568 1576
-
(2011)
The Journal of Clinical Endocrinology and Metabolism
, vol.96
, pp. E1568-1576
-
-
Ooi, E.M.1
Watts, G.F.2
Sprecher, D.L.3
Chan, D.C.4
Barrett, P.H.5
-
31
-
-
77954987061
-
PPARalpha: Energy combustion, hypolipidemia, inflammation and cancer
-
S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nuclear Receptor Signaling 8 2010 e002
-
(2010)
Nuclear Receptor Signaling
, vol.8
, pp. e002
-
-
Pyper, S.R.1
Viswakarma, N.2
Yu, S.3
Reddy, J.K.4
-
32
-
-
84887210784
-
Refocusing peroxisome proliferator activated receptor-alpha: A new insight for therapeutic roles in diabetes
-
H. Seok, and B.S. Cha Refocusing peroxisome proliferator activated receptor-alpha: a new insight for therapeutic roles in diabetes Diabetes & Metabolism Journal 37 2013 326 332
-
(2013)
Diabetes & Metabolism Journal
, vol.37
, pp. 326-332
-
-
Seok, H.1
Cha, B.S.2
-
33
-
-
79958244231
-
PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation
-
T. Varga, Z. Czimmerer, and L. Nagy PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation Biochimica et Biophysica Acta 1812 2011 1007 1022
-
(2011)
Biochimica et Biophysica Acta 1812
, pp. 1007-1022
-
-
Varga, T.1
Czimmerer, Z.2
Nagy, L.3
-
34
-
-
85014780454
-
The dual PPAR-alpha/gamma agonist aleglitazar increases number and function of endothelial progenitor cells: Implications for vascular function and atherogenesis
-
C. Werner, C. Gensch, V. Pavlickova, J. Poess, M. Wright, M. Boehm, and U. Laufs The dual PPAR-alpha/gamma agonist aleglitazar increases number and function of endothelial progenitor cells: implications for vascular function and atherogenesis European Heart Journal 34 2013 P2390
-
(2013)
European Heart Journal
, vol.34
, pp. P2390
-
-
Werner, C.1
Gensch, C.2
Pavlickova, V.3
Poess, J.4
Wright, M.5
Boehm, M.6
Laufs, U.7
-
35
-
-
84878159522
-
Development of a cell-based high-throughput peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of the extracts from Rhizoma Coptis
-
Z.N. Xia, Y.X. Lin, L.X. Guo, F.Q. Yang, P. Xu, Y.L. Zhang, and J.H. Liu Development of a cell-based high-throughput peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of the extracts from Rhizoma Coptis Journal of Asian Natural Products Research 15 2013 225 234
-
(2013)
Journal of Asian Natural Products Research
, vol.15
, pp. 225-234
-
-
Xia, Z.N.1
Lin, Y.X.2
Guo, L.X.3
Yang, F.Q.4
Xu, P.5
Zhang, Y.L.6
Liu, J.H.7
-
36
-
-
84865048500
-
Chemical constituents from Edgeworthia gardneri (Thymelaeaceae)
-
P. Xu, Z. Xia, and Y. Lin Chemical constituents from Edgeworthia gardneri (Thymelaeaceae) Biochemical Systematics and Ecology 45 2012 148 150
-
(2012)
Biochemical Systematics and Ecology
, vol.45
, pp. 148-150
-
-
Xu, P.1
Xia, Z.2
Lin, Y.3
-
38
-
-
84955496519
-
The preparation methods and application on diabetic nephropathy of the extracts of Edgeworthia gardneri (Wall.) Meisn
-
201110128975
-
G.Y. Zhong, P. Xu, Y.X. Lin, X.M. Liang, and F.Q. Yang The preparation methods and application on diabetic nephropathy of the extracts of Edgeworthia gardneri (Wall.) Meisn China Patent 201110128975 2011 9
-
(2011)
China Patent
, pp. 9
-
-
Zhong, G.Y.1
Xu, P.2
Lin, Y.X.3
Liang, X.M.4
Yang, F.Q.5
-
39
-
-
78649516943
-
Daphnodorin dimers from Edgeworthia chrysantha with α-glucosidase inhibitory activity
-
T. Zhou, S.W. Zhang, S.S. Liu, H.J. Cong, and L.J. Xuan Daphnodorin dimers from Edgeworthia chrysantha with α-glucosidase inhibitory activity Phytochemistry Letters 3 2010 242 247
-
(2010)
Phytochemistry Letters
, vol.3
, pp. 242-247
-
-
Zhou, T.1
Zhang, S.W.2
Liu, S.S.3
Cong, H.J.4
Xuan, L.J.5
|